secwatch.observer — SEC 8-K summary
======================================

Issuer:     GENELUX Corp (GNLX)
CIK:        0001231457
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001493152-23-024868
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genelux: Olvi-Vec estimated billion+ US market; interim data in recurrent NSCLC expected mid-2024
--------------------------------------------------------------------------------

- Olvi-Vec estimated to represent more than $1 billion annual US market opportunity.
- Interim data from systemic Olvi-Vec trials in recurrent NSCLC expected as early as mid-2024.
- Corporate presentation outlines pipeline and commercial potential for lead candidate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1231457/000149315223024868/0001493152-23-024868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1231457/000149315223024868/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer